Cargando…

Hospitalizations for osteoporosis-related fractures: Economic costs and clinical outcomes

BACKGROUND: Osteoporotic fractures frequently require inpatient care, and are associated with elevated risks of morbidity, mortality, and re-hospitalization. A comprehensive evaluation of healthcare costs, resource utilization, and outcomes associated with osteoporosis (OP)-related fractures treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weycker, Derek, Li, Xiaoyan, Barron, Rich, Bornheimer, Rebecca, Chandler, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440958/ https://www.ncbi.nlm.nih.gov/pubmed/28580386 http://dx.doi.org/10.1016/j.bonr.2016.07.005

Ejemplares similares

Predictors of Imminent Risk of Nonvertebral Fracture in Older, High‐Risk Women: The Framingham Osteoporosis Study
por: Hannan, Marian T, et al.
Publicado: (2019)

Determinants of imminent fracture risk in postmenopausal women with osteoporosis
por: Barron, R. L., et al.
Publicado: (2020)

Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?
por: Weycker, Derek, et al.
Publicado: (2015)

Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease
por: Bornheimer, Rebecca, et al.
Publicado: (2017)

Excess Risk of Invasive Pneumococcal Disease (IPD) Persists in Adults with Comorbid Conditions in the Era of PCV13 Childhood and Adult Immunization
por: Pelton, Stephen I, et al.
Publicado: (2017)

Pneumonia in young adults with asthma: impact on subsequent asthma exacerbations
por: Pelton, Stephen I, et al.
Publicado: (2019)

An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
por: Nshimyumukiza, Léon, et al.
Publicado: (2013)

Decline in Pneumococcal Disease Attenuated in Older Adults and Those With Comorbidities Following Universal Childhood PCV13 Immunization
por: Pelton, Stephen I, et al.
Publicado: (2019)

Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice
por: Weycker, Derek, et al.
Publicado: (2015)

Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice
por: Weycker, Derek, et al.
Publicado: (2012)

Economic Burden of Osteoporosis-Related Fractures in the US Medicare Population
por: Williams, Setareh A., et al.
Publicado: (2020)

Attributable Cost of Adult Hospitalized Pneumonia Beyond the Acute Phase
por: Weycker, Derek, et al.
Publicado: (2020)

Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis
por: Weycker, Derek, et al.
Publicado: (2014)

Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis
por: Bonafede, M. M., et al.
Publicado: (2015)

Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data
por: Bonafede, M., et al.
Publicado: (2016)

Osteoporosis associated vertebral fractures—Health economic implications
por: Joestl, Julian, et al.
Publicado: (2017)

Neuromyelitis Optica Spectrum Disorder: Clinical Burden and Cost of Relapses and Disease-Related Care in US Clinical Practice
por: Royston, Minying, et al.
Publicado: (2021)

Cost-Effectiveness of Adult Universal Hepatitis B Vaccination
por: Oster, Gerry, et al.
Publicado: (2022)

Economic inequalities amongst women with osteoporosis-related fractures: an application of concentration index decomposition
por: Moradzadeh, Rahmatollah, et al.
Publicado: (2016)

A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis
por: Söreskog, E., et al.
Publicado: (2021)

US healthcare costs attributable to type A and type B influenza
por: Yan, Songkai, et al.
Publicado: (2017)

Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
por: Weycker, Derek, et al.
Publicado: (2019)

The Costs of Confronting Osteoporosis: Cost Study of an Australian Fracture Liaison Service
por: Major, Gabor, et al.
Publicado: (2018)

Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures
por: Weycker, D., et al.
Publicado: (2017)

Management of Age-Related Osteoporosis and Prevention of Associated Fractures
por: MacLaughlin, Eric J, et al.
Publicado: (2006)

Human Evolution and Osteoporosis-Related Spinal Fractures
por: Cotter, Meghan M., et al.
Publicado: (2011)

Vertebroplasty in osteoporosis-related vertebral fractures
por: Sadat-Ali, Mir
Publicado: (2008)

Pregnancy-related osteoporosis and spinal fractures
por: Yun, Ka Yeong, et al.
Publicado: (2017)

Management of osteoporosis in patients hospitalized for hip fractures
por: Ip, T. P., et al.
Publicado: (2010)

Estimating the Fiscal Costs of Osteoporosis in Korea Applying a Public Economic Perspective
por: Connolly, Mark P., et al.
Publicado: (2019)

Relationship of American Spinal Injury Association Impairment Scale Grade to Post-injury Hospitalization and Costs in Thoracic Spinal Cord Injury
por: Dukes, Ellen M, et al.
Publicado: (2018)

The Association of Adherence to Osteoporosis Therapies with Fracture, All-Cause Medical Costs, and All-Cause Hospitalizations: A Retrospective Claims Analysis of Female Health Plan Enrollees with Osteoporosis
por: Halpern, Rachel, et al.
Publicado: (2011)

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
por: Hiligsmann, M., et al.
Publicado: (2018)

Current and Future Incidence and Costs of Osteoporosis-Related Fractures in The Netherlands: Combining Claims Data with BMD Measurements
por: Lötters, Freek J. B., et al.
Publicado: (2016)

Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective
por: Barcelos, Anabela, et al.
Publicado: (2023)

Cost-Effectiveness of Pharmacological Treatments for Osteoporosis Consistent with the Revised Economic Evaluation Guidelines for Canada
por: Coyle, Doug
Publicado: (2019)

Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study
por: Weycker, Derek, et al.
Publicado: (2019)

An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population
por: Sadat-Ali, Mir, et al.
Publicado: (2012)

Fracture liaison services: improving outcomes for patients with osteoporosis
por: Walters, Samuel, et al.
Publicado: (2017)

Direct costs of osteoporosis-related hip fractures: protocol for a cross-sectional analysis of a national database
por: Maghbooli, Zhila, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c44tc8cegomc64o0q16bp5a115